Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Aging Mammary Stem Cells and Breast Cancer Prevention
Authors not listed
LuZhe Sun · 2016
Abstract
To examine whether mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) can reduce malignant markers and aberrant mammary stem/progenitor cells (MaSCs) number in surgical specimens
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Anonymous. (2016). Aging Mammary Stem Cells and Breast Cancer Prevention. <em>LuZhe Sun</em>. https://clinicaltrials.gov/study/NCT02642094
Vancouver
Anonymous. Aging Mammary Stem Cells and Breast Cancer Prevention. LuZhe Sun. 2016.
BibTeX
@misc{anon2016AgingM,
title = {Aging Mammary Stem Cells and Breast Cancer Prevention},
author = {Anonymous},
journal = {LuZhe Sun},
year = {2016},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging 2020
Open access · OA
Rapamycin for aging stem cells
2020
Citation only
Stem Cells and Aging
Molecular and Cellular Endocrinology 2016
Preprint · CC-BY
Aging, metabolism and stem cells: Spotlight on muscle stem cells
Current topics in developmental biology/Current Topics in Developmental Biology 2017
Citation only
Muscle Stem Cells and Aging
Biochimica et Biophysica Acta (BBA) - Bioenergetics 2015
Open access · OA
Stem cells, mitochondria and aging
Springer eBooks 2018
Citation only